Sputnik V Vaccine approved in India

  • The expert panel of country's drug regulator on Monday approved the use of Russia's Sputnik V Covid-19 vaccine. 
  • The decision comes after Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) met to take up Sputnik V application for Emergency Use Authorization in India. 
  • This is the third Covid vaccine to be available in India. 
  • The first two are Serum Institute of India's locally-made Oxford Covid-19 vaccine 'Covishield' and Bharat Biotech's indigenously manufactured Covaxin.
SPUTNIK V
  • This is a vaccine that uses two different human common cold viruses (adenovirus) that have been modified so that the gene causing the cold infection is removed and instead replaced with a code to make SARS-CoV-2’s ‘spike protein’.
  • The human adenoviruses then act as a vehicle to transport this code to the cells when a person is vaccinated, so that the body can develop an immune response in the form of antibodies to protect it in the event the real virus tries to infect. 
  • The vaccine, named after the first Soviet space satellite, was developed by Moscow’s Gamaleya National Research Institute of Epidemiology and Microbiology.
  • Sputnik V has demonstrated an efficacy rate of 91.6% in the interim analysis of phase 3 clinical trial, which included data on 19,866 volunteers in Russia.

Comments

Popular posts from this blog

Hamas V. PLO

G7 global corporate Tax Deal

The statue of Swami Vivekananda at the JNU campus